首页> 外文OA文献 >ATCT-35QUALITY OF LIFE, COGNITIVE FUNCTION AND FUNCTIONAL STATUS IN THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF TTFIELDS WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM

【2h】

ATCT-35QUALITY OF LIFE, COGNITIVE FUNCTION AND FUNCTIONAL STATUS IN THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF TTFIELDS WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM

机译：EF-14试验中的寿命，认知功能和功能状况，与替替替替莫蛋白的TTFIELDS的前瞻性多中心试验，与单独的新诊断的GBM患者相比

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jay-Jiguang Zhu; Susan Pannullo; Maximilian Mehdorn; Franz Payer; Nicholas Avgeropoulos; Andrea Salmaggi; Antonio Silvani; Alessandro Olivi; Samuel Goldlust; Carlos David; Alexandra Benouaich-Amiel; Eilon Kirson; Zvi Ram; Roger Stupp;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Analysis of RTOG-RPA Scores in the Phase 3 EF-14 Trial of Tumor Treating Fields with Temozolomide (TTFields/TMZ) Versus TMZ Alone in Newly Diagnosed Glioblastoma. [J] . Choe K. International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：单独在新诊断的胶质母细胞瘤中，在新诊断的胶质母细胞瘤中分析肿瘤治疗肿瘤治疗田间肿瘤治疗田间的rTOG-RPA分数。
2. STANDARD OF CARE TEMOZOLOMIDE CHEMOTHERAPY +/- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA. FINAL RESULTS OF THE PHASE III EF-14 CLINICAL TRIAL [J] . Stupp R., Ram Z. Neuro-Oncology . 2017,第MAySuppla3期

机译：新诊断的胶质母细胞瘤中替莫唑胺化学治疗+/-肿瘤治疗场（TTFIELDS）的标准。 III期EF-14临床试验的最终结果
3. Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial [J] . Weller Johannes, Tzaridis Theophilos, Mack Frederic, The lancet oncology . 2019,第10期

机译：与新诊断的MgMT-甲基化胶质细胞瘤（Ceteg / NoA-09）的患者患者与Lomustine-temozolomide与替莫斯汀 - 替莫替莫唑胺类患者有关的生活质量和神经过度认知功能
4. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
5. A randomized controlled trial of group cognitive-behavioral therapy for patients with bipolar disorder: Effects on social functioning and quality of life. [D] . Parkins, Monica M. 2013

机译：躁郁症患者团体认知行为治疗的随机对照试验：对社会功能和生活质量的影响。
6. ATCT-35QUALITY OF LIFE COGNITIVE FUNCTION AND FUNCTIONAL STATUS IN THE EF-14 TRIAL: A PROSPECTIVE MULTI-CENTER TRIAL OF TTFIELDS WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM [O] . Jay-Jiguang Zhu, Susan Pannullo, Maximilian Mehdorn, 2015

机译：EF-14试验中生活认知功能和功能状态的ATCT-35质量：新诊断为GBM的患者将替莫唑胺与替莫唑胺相比替莫唑胺与TTFIELDS进行多中心预后试验
7. NCOG-05. TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA [O] . Garth A Nicholas, Holger Hirte, Jacob Easaw, 2017

机译：ncog-05。肿瘤治疗肿瘤对治疗田间患者的三相试验的时间和认知下降的时间在新诊断的胶质母细胞瘤患者中

ATCT-35QUALITY OF LIFE, COGNITIVE FUNCTION AND FUNCTIONAL STATUS IN THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF TTFIELDS WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM

著录项

引文网络

相似文献

相关主题

期刊订阅